This is read by an automated voice. Please report any issues or inconsistencies here. Antares, a Torrance-based startup focused on micronuclear reactor development, raised $96 million in a Series B ...

Nuclear startup Antares said Tuesday it has raised $96 million in Series B funding as it pursues its small modular reactor design. The round, which was led by Shine Capital with participation from Alt ...

Antares, an advanced nuclear energy startup, today announced the close of its $96 million Series B funding round. The round was led by Shine Capital, with participation from Alt Capital, Caffeinated, ...

IDAHO FALLS, Idaho (KIFI)– Antares Industries celebrated its expansion to Idaho with a ribbon-cutting ceremony in the Rogers building Monday morning. A leading developer of advanced micro nuclear ...

National, state and local leaders from Idaho were present for Antares Industries officially opening an office in Idaho Falls on Monday morning. Antares Industries (often referred to simply as Antares) ...

This video was produced by Wojtek Jakubiec as part of the CBC Creator Network. Learn more about the Creator Network here. Wearing a blue blazer and a cap emblazoned with the word "captain," Kamal ...

The Moon passes 0.6° south of Scorpius’ alpha star, Antares, at 2 P.M. EDT and sits just to the left of the red giant in the southwest an hour after sunset. You’ll have another hour after that of ...

Good day, and thank you for standing by. Welcome to the conference call to discuss Crane NXT's agreement to acquire Antares Vision. [Operator Instructions]. Please be advised that today's conference ...

France has officially entered the space race with a rocket named Orbital Baguette One. The country known for wine, cheese and existential cinema is now hoping to take over the cosmos with a crusty ...

Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. Skywatchers will be treated to a striking celestial pairing ...

The team that steered a clinical-stage cancer drug to an acquisition by Eli Lilly is back at it again, unveiling a new venture supported by $177 million for a pipeline of precision medicines ...

After Eli Lilly snapped up Scorpion Therapeutics' PI3Kα program earlier this year, the biotech is selling off its other two clinical assets and spinning out a new company to advance its three ...